New Zealand - engelsk - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - zuclopenthixol hydrochloride 11.82mg equivalent to 10 mg zuclopenthixol - tablet - 10 mg - active: zuclopenthixol hydrochloride 11.82mg equivalent to 10 mg zuclopenthixol excipient: copovidone ethanol glycerol hydrogenated castor oil hypromellose as part of opadry red 02f250002 iron oxide red as part of opadry red 02f250002 lactose monohydrate macrogol 6000 as part of opadry red 02f250002 magnesium stearate microcrystalline cellulose potato starch purified talc titanium dioxide as part of opadry red 02f250002 - acute and chronic schizophrenia and other psychoses, especially those with symptoms such as hallucinations, delusions, thought disturbances, agitation, restlessness, hostility or aggressiveness. manic phase of manic depressive illness. mental retardation associated with psychomotor hyperactivity, agitation, violence and other behavioural disturbances. senile dementia with significant paranoid ideas, confusion, disorientation or behavioural disturbances.

Israel - engelsk - Ministry of Health

lundbeck israel ltd. - zuclopenthixol as dihydrochloride - film coated tablets - zuclopenthixol as dihydrochloride 10 mg - zuclopenthixol - zuclopenthixol - acute schizophrenia .other acute psychoses.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

lundbeck australia pty ltd - zuclopenthixol hydrochloride, quantity: 11.8 mg (equivalent: zuclopenthixol, qty 10 mg) - tablet, film coated - excipient ingredients: copovidone; purified talc; microcrystalline cellulose; lactose monohydrate; glycerol; potato starch; magnesium stearate; hydrogenated castor oil; titanium dioxide; hypromellose; macrogol 6000; iron oxide red - safety related notification and ammended text of the product information approved as described in the letter dated 28 may 2008 from ceu1. (sub#2008-1319-1) clopixol tablets: acute and chronic schizophrenia and other psychoses, especially those with symptoms such as hallucinations, delusions, thought disturbances, agitation, restlessness, hostility or aggressiveness. manic phase of manic depressive illness.

Israel - engelsk - Ministry of Health

lundbeck israel ltd. - zuclopenthixol as dihydrochloride - film coated tablets - zuclopenthixol as dihydrochloride 2 mg - zuclopenthixol - zuclopenthixol - acute schizophrenia, other acute psycoses.

Israel - engelsk - Ministry of Health

lundbeck israel ltd. - zuclopenthixol as dihydrochloride - film coated tablets - zuclopenthixol as dihydrochloride 25 mg - zuclopenthixol - zuclopenthixol - acute schizophrenia. other acute psychoses.

Belgia - nederlandsk - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

lundbeck sa-nv - zuclopenthixoldihydrochloride 2,364 mg - eq. zuclopenthixol 2 mg - filmomhulde tablet - 2 mg - zuclopenthixoldihydrochloride 2.364 mg - zuclopenthixol

Belgia - nederlandsk - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

lundbeck sa-nv - zuclopenthixoldihydrochloride 11,82 mg - eq. zuclopenthixol 10 mg - filmomhulde tablet - 10 mg - zuclopenthixoldihydrochloride 11.82 mg - zuclopenthixol

Belgia - nederlandsk - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

lundbeck sa-nv - zuclopenthixoldihydrochloride 23,64 mg/ml - eq. zuclopenthixol 20 mg/ml - druppels voor oraal gebruik, vloeistof - 20 mg/ml - zuclopenthixoldihydrochloride 23.64 mg/ml - zuclopenthixol

Belgia - nederlandsk - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

lundbeck sa-nv - zuclopenthixoldihydrochloride 29,55 mg - eq. zuclopenthixol 25 mg - filmomhulde tablet - 25 mg - zuclopenthixoldihydrochloride 29.55 mg - zuclopenthixol

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - zuclopenthixol hydrochloride 25mg - tablet - 25 mg - active: zuclopenthixol hydrochloride 25mg